HZBio1

· Hangzhou Grand Biologic Pharmaceutical, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HZBio1, covering 2025-05-13 to 2025-05-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of of HZBio1 in Healthy Subjects [Phase 1]

See pricing